These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38617791)

  • 1. The value of high-risk clinicopathologic features for chemotherapy in stage I non-small cell lung cancer: a propensity score-matched study.
    Luan K; Addeo A; Flores RM; Seki N; Liu A
    J Thorac Dis; 2024 Mar; 16(3):2125-2141. PubMed ID: 38617791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of adjuvant chemotherapy on patients with stage IB non-small cell lung cancer with visceral pleural invasion.
    Kim BG; Choi J; Lee SK; Choi SI; Park CK; Sim JK; Lee H; Kim SH; Sohn JW; Yoon HJ; Lee SY; Park DW
    J Thorac Dis; 2024 Feb; 16(2):875-883. PubMed ID: 38505035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Adjuvant Chemotherapy on Survival of Patients With 8th Edition Stage IB Non-Small Cell Lung Cancer.
    Xu Y; Wan B; Zhu S; Zhang T; Xie J; Liu H; Zhan P; Lv T; Song Y
    Front Oncol; 2021; 11():784289. PubMed ID: 35155190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of visceral pleural invasion on the association of extent of lymphadenectomy and survival in stage I non-small cell lung cancer.
    Wo Y; Zhao Y; Qiu T; Li S; Wang Y; Lu T; Qin Y; Song G; Miao S; Sun X; Liu A; Kong D; Dong Y; Leng X; Du W; Jiao W
    Cancer Med; 2019 Feb; 8(2):669-678. PubMed ID: 30706688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment Modality for Stage IB Peripheral Non-Small Cell Lung Cancer With Visceral Pleural Invasion and ≤3 cm in Size.
    Huang W; Deng HY; Lin MY; Xu K; Zhang YX; Yuan C; Zhou Q
    Front Oncol; 2022; 12():830470. PubMed ID: 35280762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of visceral pleural invasion in the stage pT
    Zhang X; Xie J; Hu S; Peng W; Xu B; Li Y; Li C
    Curr Probl Cancer; 2021 Feb; 45(1):100640. PubMed ID: 32828574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy for visceral pleural invasion in 3-4-cm non-small-cell lung cancer improves survival.
    Wightman SC; Lee JY; Ding L; Atay SM; Shemanski KA; McFadden PM; David EA; Kim AW
    Eur J Cardiothorac Surg; 2022 Jun; 62(1):. PubMed ID: 35325098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of adjuvant chemotherapy on survival of patients with stage IB non-small cell lung cancer with visceral pleural invasion.
    Xie J; Zhang X; Hu S; Peng WD; Xu B; Li Y; Zhang SJ; Li Q; Li C
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2231-2239. PubMed ID: 32533405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Survival With Adjuvant Chemotherapy Among Patients With Early-Stage Non-Small Cell Lung Cancer With vs Without High-Risk Clinicopathologic Features.
    Pathak R; Goldberg SB; Canavan M; Herrin J; Hoag JR; Salazar MC; Papageorge M; Ermer T; Boffa DJ
    JAMA Oncol; 2020 Nov; 6(11):1741-1750. PubMed ID: 32940636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of adjuvant chemotherapy on survival for patients with stage IB and IIA non-small cell lung cancer.
    Zhang P; Duan J; Bai H; Wang Z; Gao S; Tan F; Gao Y; Wang X; Wan R; Xu J; He X; Feng X; Yu R; Sun J; Zhao Z; Fei K; Li N; He J; Wang J
    Thorac Cancer; 2021 Jan; 12(1):30-39. PubMed ID: 33111432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overall Survival Analyses following Adjuvant Chemotherapy or Nonadjuvant Chemotherapy in Patients with Stage IB Non-Small-Cell Lung Cancer.
    Tu Z; Tian T; Chen Q; Li C
    J Oncol; 2021; 2021():8052752. PubMed ID: 34335761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of adjuvant chemotherapy for completely resected stage IB non-small cell lung cancer: a retrospective study.
    Park HJ; Park HS; Cha YJ; Lee S; Jeung HC; Cho JY; Kim HJ; Byun MK
    J Thorac Dis; 2018 Apr; 10(4):2279-2287. PubMed ID: 29850132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sublobectomy versus lobectomy for long-term survival outcomes of early-stage non-small cell lung cancer with a tumor size ≤2 cm accompanied by visceral pleural invasion: a SEER population-based study.
    Yu Y; Huang R; Wang P; Wang S; Ling X; Zhang P; Yu J; Wang J; Xiao J; Wang Z
    J Thorac Dis; 2020 Mar; 12(3):592-604. PubMed ID: 32274125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy may improve long-term outcomes in stage IB non-small cell lung cancer patients with previous malignancies: A propensity score-matched analysis.
    Zhou K; Zhao Y; Liang L; Cao J; Lin H; Peng Z; Mei J
    Front Oncol; 2022; 12():938195. PubMed ID: 36119504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of adjuvant chemotherapy on survival for patients with completely resected high-risk stage IB NSCLC.
    Shen ZQ; Feng KP; Fang ZY; Xia T; Pan S; Ding C; Xu C; Ju S; Chen J; Li C; Zhao J
    J Cardiothorac Surg; 2024 Jan; 19(1):1. PubMed ID: 38166960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of visceral pleural invasion in node-negative non-small cell lung cancer: a systematic review and meta-analysis.
    Jiang L; Liang W; Shen J; Chen X; Shi X; He J; Yang C; He J
    Chest; 2015 Oct; 148(4):903-911. PubMed ID: 25675151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival Following Segmentectomy or Lobectomy in Patients With Stage IB Non-small-cell Lung Cancer.
    Hao B; Zhang L; Fan T; Liu B; Jiang W; Hu H; Geng Q
    Front Oncol; 2020; 10():661. PubMed ID: 32500023
    [No Abstract]   [Full Text] [Related]  

  • 18. Visceral pleural invasion in T1 tumors (≤3 cm), particularly T1a, in the eighth tumor-node-metastasis classification system for non-small cell lung cancer: a population-based study.
    Zhang T; Zhang JT; Li WF; Lin JT; Liu SY; Yan HH; Yang JJ; Yang XN; Wu YL; Nie Q; Zhong WZ
    J Thorac Dis; 2019 Jul; 11(7):2754-2762. PubMed ID: 31463103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic relevance of pleural invasion for resected NSCLC patients undergoing adjuvant treatments: A propensity score-matched analysis of SEER database.
    De Giglio A; Di Federico A; Gelsomino F; Ardizzoni A
    Lung Cancer; 2021 Nov; 161():18-25. PubMed ID: 34492552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of clinical T4 stage superior sulcus non-small cell lung cancer: a propensity-matched analysis of the surveillance, epidemiology, and end results database.
    Wen J; Liu D; Chen D; Chen J; Xu X; Chen C; Zhang F; Duan S; Zhu R; Fan M; Chen Y
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30647107
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.